CD8A and Epstein-Barr virus infection: Mice reconstituted with human HLA-DR15 hematopoietic progenitor cells displayed significantly greater numbers of activated CD8+T cells in the periphery (blood and spleen), at 4-6 weeks post EBV infection, compared to controls.